Description
Rosuvastatin 1 0mg/20mg
In patients with CVD risk Prevent, halt & fight Heart disease
- Raises HDL-C significantly more than pravastatin1
- Reduces CV events by 44% and mortality by 20%
- Reduces serum triglyceride levels by 22% than simvastatin and pravastatin after 12 weeks’ treatment
- Achieves LDL-cholesterol levels 28% more than pravastatin2
Indicated in
- Cardiovascular Death
- Stroke
- Myocardial Infarction
- Unstable Angina
Reviews
There are no reviews yet.